223 related articles for article (PubMed ID: 14630274)
1. Intraluminal low-dose-rate 192Ir brachytherapy combined with external beam radiotherapy and biliary stenting for unresectable extrahepatic bile duct carcinoma.
Takamura A; Saito H; Kamada T; Hiramatsu K; Takeuchi S; Hasegawa M; Miyamoto N
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1357-65. PubMed ID: 14630274
[TBL] [Abstract][Full Text] [Related]
2. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy.
Kamada T; Saitou H; Takamura A; Nojima T; Okushiba SI
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):767-74. PubMed ID: 8598352
[TBL] [Abstract][Full Text] [Related]
3. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer.
Alden ME; Mohiuddin M
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):945-51. PubMed ID: 8138448
[TBL] [Abstract][Full Text] [Related]
4. A Phase I study of high-dose-rate intraluminal brachytherapy as palliative treatment in extrahepatic biliary tract cancer.
Mattiucci GC; Autorino R; Tringali A; Perri V; Balducci M; Deodato F; Gambacorta MA; Mantini G; Tagliaferri L; Mutignani M; Morganti AG
Brachytherapy; 2015; 14(3):401-4. PubMed ID: 25591935
[TBL] [Abstract][Full Text] [Related]
5. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
Deodato F; Clemente G; Mattiucci GC; Macchia G; Costamagna G; Giuliante F; Smaniotto D; Luzi S; Valentini V; Mutignani M; Nuzzo G; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):483-8. PubMed ID: 16242254
[TBL] [Abstract][Full Text] [Related]
6. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts.
Shin HS; Seong J; Kim WC; Lee HS; Moon SR; Lee IJ; Lee KK; Park KR; Suh CO; Kim GE
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):105-12. PubMed ID: 12909222
[TBL] [Abstract][Full Text] [Related]
7. Combined modality treatment in unresectable extrahepatic biliary carcinoma.
Morganti AG; Trodella L; Valentini V; Montemaggi P; Costamagna G; Smaniotto D; Luzi S; Ziccarelli P; Macchia G; Perri V; Mutignani M; Cellini N
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):913-9. PubMed ID: 10705013
[TBL] [Abstract][Full Text] [Related]
8. Combined external beam radiotherapy and intraluminal high dose rate brachytherapy on bile duct carcinomas.
Fritz P; Brambs HJ; Schraube P; Freund U; Berns C; Wannenmacher M
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):855-61. PubMed ID: 8040034
[TBL] [Abstract][Full Text] [Related]
9. Intraluminal brachytherapy in the treatment of bile duct carcinomas.
Leung JT; Kuan R
Australas Radiol; 1997 May; 41(2):151-4. PubMed ID: 9153812
[TBL] [Abstract][Full Text] [Related]
10. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
11. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy.
Eschelman DJ; Shapiro MJ; Bonn J; Sullivan KL; Alden ME; Hovsepian DM; Gardiner GA
Radiology; 1996 Sep; 200(3):717-24. PubMed ID: 8756921
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer.
Nomura M; Yamakado K; Nomoto Y; Nakatsuka A; Ii N; Shoji K; Takeda K
Int J Oncol; 2002 Feb; 20(2):325-31. PubMed ID: 11788896
[TBL] [Abstract][Full Text] [Related]
13. Biliary tree malignancies: the University of Minnesota experience.
Lee CK; Barrios BR; Bjarnason H
J Surg Oncol; 1997 Aug; 65(4):298-305. PubMed ID: 9274796
[TBL] [Abstract][Full Text] [Related]
14. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
15. External beam and intraluminal radiotherapy for locally advanced bile duct cancer: role and tolerability.
Vallis KA; Benjamin IS; Munro AJ; Adam A; Foster CS; Williamson RC; Kerr GR; Price P
Radiother Oncol; 1996 Oct; 41(1):61-6. PubMed ID: 8961369
[TBL] [Abstract][Full Text] [Related]
16. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma.
Foo ML; Gunderson LL; Bender CE; Buskirk SJ
Int J Radiat Oncol Biol Phys; 1997 Nov; 39(4):929-35. PubMed ID: 9369143
[TBL] [Abstract][Full Text] [Related]
17. Relief of jaundice by external beam radiotherapy and intraluminal brachytherapy in patients with extrahepatic cholangiocarcinoma: results without stenting.
Ishii H; Furuse J; Nagase M; Kawashima M; Ikeda H; Yoshino M
Hepatogastroenterology; 2004; 51(58):954-7. PubMed ID: 15239222
[TBL] [Abstract][Full Text] [Related]
18. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?
Montemaggi P; Morganti AG; Dobelbower RR; Brizi G; Smaniotto D; Costamagna G; Cellini N; Marano P
Radiology; 1996 Jun; 199(3):861-6. PubMed ID: 8638018
[TBL] [Abstract][Full Text] [Related]
19. High-dose-rate remote afterloading intracavitary brachytherapy for the treatment of extrahepatic biliary duct carcinoma.
Lu JJ; Bains YS; Abdel-Wahab M; Brandon AH; Wolfson AH; Raub WA; Wilkinson CM; Markoe AM
Cancer J; 2002; 8(1):74-8. PubMed ID: 11895206
[TBL] [Abstract][Full Text] [Related]
20. Unresectable perihilar cholangiocarcinoma: multimodal palliative treatment.
Mosconi C; Renzulli M; Giampalma E; Galuppi A; Balacchi C; Brandi G; Ercolani G; Bianchi G; Golfieri R
Anticancer Res; 2013 Jun; 33(6):2747-53. PubMed ID: 23749936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
